IBCSG -: International Breast Cancer Study Group IBCSG trial 11-93 design:: N+, ER+ or PgR+, premenopausal breast cancer

被引:1
|
作者
Thürlimann, B [1 ]
机构
[1] IBCSG Coordinat Ctr, CH-3008 Bern, Switzerland
来源
ONKOLOGIE | 1998年 / 21卷 / 03期
关键词
D O I
10.1159/000026817
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:266 / 267
页数:2
相关论文
共 50 条
  • [1] Menstrual cycle and timing of breast surgery in premenopausal node-positive breast cancer: Results of the International Breast Cancer Study Group (IBCSG) Trial VI
    Goldhirsch, A
    Gelber, RD
    Castiglione, M
    ONeill, A
    Thurlimann, B
    Rudenstam, CM
    Lindtner, J
    Collins, J
    Forbes, J
    Crivellari, D
    Coates, A
    Cavalli, F
    Simoncini, E
    Fey, MF
    Pagani, O
    Price, K
    Senn, HJ
    ANNALS OF ONCOLOGY, 1997, 8 (08) : 751 - 756
  • [2] Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials
    Huober, J.
    Gelber, S.
    Goldhirsch, A.
    Coates, A. S.
    Viale, G.
    Oehlschlegel, C.
    Price, K. N.
    Gelber, R. D.
    Regan, M. M.
    Thuerlimann, B.
    ANNALS OF ONCOLOGY, 2012, 23 (11) : 2843 - 2851
  • [3] Prognosis of medullary breast cancer: Analyses of 13 International Breast Cancer Study Group (IBCSG) trials.
    Huober, J. B.
    Gelber, S.
    Thuerlimann, El.
    Regan, M. M.
    Price, K. N.
    Goldhirsch, A.
    Coates, A. S.
    Viale, G.
    Oehischiegei, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement:: Results of the International Breast Cancer Study Group (IBCSG) Trial VI
    Pagani, O
    O'Neill, A
    Castiglione, M
    Gelber, RD
    Goldhirsch, A
    Rudenstam, CM
    Lindtner, J
    Collins, J
    Crivellari, D
    Coates, A
    Cavalli, F
    Thürlimann, B
    Simoncini, E
    Fey, M
    Price, K
    Senn, HJ
    EUROPEAN JOURNAL OF CANCER, 1998, 34 (05) : 632 - 640
  • [5] Chemoendocrine therapy for node-negative breast cancer: international breast cancer study group (IBCSG) trials VIII and IX.
    Castiglione-Gertsch, MM
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S31 - S31
  • [6] Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)
    Pestalozzi, BC
    Zahrieh, D
    Price, KN
    Holmberg, SB
    Lindtner, J
    Collins, J
    Crivellari, D
    Fey, MF
    Murray, E
    Pagani, O
    Simoncini, E
    Castiglione-Gertsch, M
    Gelber, RD
    Coates, AS
    Goldhirsch, A
    ANNALS OF ONCOLOGY, 2006, 17 (06) : 935 - 944
  • [7] The SNAP trial: Schedules of nab-paclitaxel in metastatic breast cancer, International breast cancer study group (IBCSG 42-12) and breast International group (BIG 2-12)
    Gennari, A.
    Jerusalem, G.
    Maibach, R.
    CANCER RESEARCH, 2013, 73
  • [8] The SOLE Trial: International Breast Cancer Study Group (IBCSG 35-07) and Breast International Group (BIG 1-07) Study of Letrozole Extension.
    Colleoni, M.
    CANCER RESEARCH, 2011, 71
  • [9] Mutational analysis of triple-negative breast cancers within the International Breast Cancer Study Group (IBCSG) Trial 22-00
    Munzone, Elisabetta
    Gray, Kathryn P.
    Fumagalli, Caterina
    Guerini-Rocco, Elena
    Lang, Istvan
    Ruhstaller, Thomas
    Gianni, Lorenzo
    Kammler, Roswitha
    Viale, Giuseppe
    Di Leo, Angelo
    Coates, Alan S.
    Gelber, Richard D.
    Regan, Meredith M.
    Goldhirsch, Aron
    Barberis, Massimo
    Colleoni, Marco
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 170 (02) : 351 - 360
  • [10] Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93
    Thuerlimann, Beat
    Price, Karen N.
    Gelber, Richard D.
    Holmberg, Stig B.
    Crivellari, Diana
    Colleoni, Marco
    Collins, John
    Forbes, John F.
    Castiglione-Gertsch, Monica
    Coates, Alan S.
    Goldhirsch, Aron
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 113 (01) : 137 - 144